Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel calcium-sensing receptor agonists designed by Leo Pharma

June 22, 2012

Sirona Biochem reports findings on SGLT inhibitor in primates

June 21, 2012

Alnylam product receives orphan drug status

June 21, 2012

Researchers at Leo Pharma synthesize novel CaSR agonists

June 21, 2012

EMA validates MAAs for fixed-dose combination diabetes therapies

June 20, 2012

French center synthesizes new agents for bone disorders

June 20, 2012

Jenrin Discovery develops new agents targeting CB1 receptor

June 20, 2012

AstraZeneca stops AZD-2820 study

June 20, 2012

Transition Therapeutics reports on TT-401 study

June 19, 2012

Lysogene advances gene therapy study in Sanfilippo type A syndrome

June 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...